The Heart of America Association of Blood Banks is a nonprofit, professional organization dedicated to improving Transfusion Medicine by fostering the exchange of information and bringing education opportunities to blood bank and transfusion medicine professionals.  The HAABB hosts two annual meetings for the Kansas City & St Louis areas. 








2010 Fall Meeting Review



The Fall HAABB meeting was held on September 15th, 2010 at the DoubleTree Hotel and Coference Center in Chesterfield, MO.  The meeting was started with a warm welcome and exciting "know your blood bank" game by HAABB president, Elizabeth Jones.  The game continued throughout the day and prizes were given to all winners.  We would like to thank all who were able to attend this successful meeting and hope to see you again at the next HAABB meeting. 


HAABB Registration Table
Ready to start the meeting...

A special THANK YOU to all of the vendors.  Vendor participation ensures that we can continue these programs.  In addition to exhibiting at the meeting, many supported the organization by sponsoring education sessions and providing raffle prizes.   


BioRad provided sponsorship for the morning session.

Jaime Houghton's presentation was sponsroeed by Fenwal.

ZymoGenetics Provided sponsorship for Dr. Creer's presentation.


Exhibiting Vendors:

American Red Cross


CSL Behring

Community Blood Center of KC



Med Alliance Group

Mississippi Valley Regional Blood Center


Vendor Exhibit
Vendor Exhibit
Vendor Exhibit
Vendor Exhibit

Fall 2010 HAABB Meeting: Program Overview


Sailing through a Work-up

Elaine Scott, MT(ASCP)SBB, American Red Cross, MO/IL Region, St. Louis, MO

    Elaine presented an interesting case where the Immunohematology Reference Laboratory used "thinking

    outside of the box" as a tool for resolving incompatible crossmatches in a patient with multiple alloantibodies.


Implementing a Transfusion Safety Program

Daniel S. Smith, MD, Professor of Transfusion Medicine, Indiana University, Indianapolis, IN


ABO Mystery Theatre: To B or Not To B!

David Baker, MBA, MT(ASCP), Children’s Hospital, St. Louis, MO    

    Discussed a case of passenger lymphocyte syndrome affecting a patient at SLCH.  Reviewed the frequency

    and typical outcomes of the syndrome.  Passenger Lymphocyte Syndrome refers to the clinical phenomenon

    of alloimmune hemolysis resulting from the adoptive transfer of viable lymphocytes from the donor during

    solid organ and hematopoietic stem cell transplants.  Donor's antibodies can be of ABO or non-ABO origin. 

    Management strategies include immunosuppression, immune-modulation (IVIG), B-Cell targeting (Rituximab)

    and/or exchange transfusion.


“Local Boyd Makes Good”; William Clouser Boyd Blood Groups and Anthropology

Steve Pierce, SBB(ASCP), Retired, Kansas City, MO

    Following Ludwig Hirszfeld's report in 1919 that ABO prevalence varied in different populations, blood

    groups became widely used in physical anthropology.  William Clouser Boyd, from Missouri, was one of the

    leading Americans to use blood groups in anthropological investigations.  He was the first to type Egyptian

    mummies and introduced the use of lectins to Type red blood cells.  This historical presentation examined

    seroanthropology and Boyd's contributions to blood group serology.


Platelet Additive Solution: How Can Something So Simple Be So Complicated?

Peyton S. Metzel, PhD, Vice President, Scientific Affairs, Fenwal Inc, Lake Zurich, IL         


Are You My Mother? In Vitro Fertility Challenges in the Blood Bank

Faith Nilhas, MLS(ASCP), Blood Bank, Lawrence Memorial Hospital, Lawrence, KS

    Investigation of ABORh discrepancies between cord bloods of newborns and their mothers is important to

    rule out possible mislabeling of specimens and to assure testing is correct to prevent possible D

    alloiommunization of Rh Negative women.  This case study discussed the discovery that in vitro fertilization

    methods may have been used to achieve pregnancy and that sensitive privacy issues can arise as a result of

    the Blood Bank needing to resolve ABO discrepancies.


Monoclonal Reagent Case Studies                      

Christina Barron, MT(ASCP)SBB, American Red Cross, MO/IL Region, St. Louis, MO

    Knowing the clones that are used to manufacture your monoclonal reagents can make a big difference in the results you

    obtain.  Chris presented several examples typing discrepancies that ultimately were resolved by evualting the clones in

    the reagents used.  A wonderful table was also provided.


Immune-Mediated Coagulopathy Following Topical Hemostat Use                    

Michael Creer, MD, Professor of Pathology and Laboratory Medicine

St. Louis University School of Medicine, St. Louis, MO